Cargando…
How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
Background: Glycoprotein IIB/IIIA inhibitors are occasionally utilized during carotid artery stenting (CAS) in the presence or absence of a visualized intra-operative thrombus. Objective: We assess the hemorrhagic and clinical outcomes associated with the use of eptifibatide during CAS. Methods: A r...
Autores principales: | Allam, Hesham, Vora, Nirav, Edgell, Randall C., Callison, R. Charles, Al-Khalili, Yasir, Storkan, Michelle, Alshekhlee, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569662/ https://www.ncbi.nlm.nih.gov/pubmed/23408773 http://dx.doi.org/10.3389/fneur.2013.00004 |
Ejemplares similares
-
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020) -
Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014) -
Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014) -
Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016) -
Urgent Carotid Artery Stenting with Intracranial and Carotid Stent for Symptomatic Bilateral Consecutive Internal Carotid Artery Dissection: A Case Report
por: TAKANO, Yuki, et al.
Publicado: (2022)